BioLineRx (BLRX) Equity Ratio (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

BioLineRx has reported Equity Ratio over the past 2 years, most recently at 0.44 for Q4 2025.

• Quarterly results put Equity Ratio at 0.44 for Q4 2025, up 28.57% from a year ago — trailing twelve months through Dec 2025 was 0.08 (up 60.04% YoY), and the annual figure for FY2025 was 0.44, up 28.57%.
• Equity Ratio for Q4 2025 was 0.44 at BioLineRx, up from 0.35 in the prior quarter.
• Over the last five years, Equity Ratio for BLRX hit a ceiling of 0.44 in Q4 2025 and a floor of 0.35 in Q4 2024.

Peer Comparison